Longitudinal Analysis of Reticular Drusen Associated With Geographic Atrophy in Age-Related Macular Degeneration

To characterize longitudinal changes of reticular drusen (RDR) in subjects with geographic atrophy (GA) secondary to age-related macular degeneration in the multicenter, prospective natural history Geographic Atrophy Progression Study. Three-field confocal scanning laser ophthalmoscopy fundus autofl...

Full description

Saved in:
Bibliographic Details
Published inInvestigative ophthalmology & visual science Vol. 54; no. 6; p. 4054
Main Authors Steinberg, Julia S., Auge, Jasmin, Jaffe, Glenn J., Fleckenstein, Monika, Holz, Frank G., Schmitz-Valckenberg, Steffen
Format Journal Article
LanguageEnglish
Published United States 10.06.2013
Subjects
Online AccessGet full text
ISSN1552-5783
1552-5783
DOI10.1167/iovs.12-11538

Cover

Abstract To characterize longitudinal changes of reticular drusen (RDR) in subjects with geographic atrophy (GA) secondary to age-related macular degeneration in the multicenter, prospective natural history Geographic Atrophy Progression Study. Three-field confocal scanning laser ophthalmoscopy fundus autofluorescence (cSLO FAF, excitation [exc.] = 488 nm; emission [em.] 500-800 nm, Heidelberg Retina Angiograph/Spectralis) of 44 eyes of 22 patients with RDR (median age 77.6 years; range, 61-90 years) at baseline were identified in the study population and included for further analysis. Two independent readers determined the presence, topographic distribution, and pattern of RDR at baseline and at 18 months. Furthermore, the convex hull of the extent of RDR as the minimum polygon encompassing the entire area of RDR involvement was quantified. RDR lesion boundaries were clearly detectable in all directions within three-field FAF composite images in 16 eyes of 10 patients at both baseline and final visits. Over time, RDR-affected retinal area and RDR density increased. Quantitative analysis showed a mean average RDR extent of 53.7 mm(2) (95% confidence interval [95% CI]; 40.7; 66.8) at baseline. The mean differences for intraobserver agreements were 2.4 mm(2) (95% CI; -0.1; 4.9) for reader 1 and -0.6 mm(2) (95% CI; -2.3; 1.1) for reader 2. The mean difference of interobserver agreement was 0.9 mm(2) (95% CI; -0.8; 2.7). A mean growth rate of the RDR extent within the three-field FAF composite image of 4.4 mm(2)/y (95% CI; 1.9; 6.9) was measured. In vivo cSLO FAF imaging allows for both qualitative and quantitative mapping of longitudinal changes of RDR areas within a relatively short time period. Continuous enlargement of the affected retinal area indicates disease progression with regard to this phenotypic characteristic associated with GA in AMD. Systematic recordings of RDR progression appears warranted in future natural history and interventional studies in dry AMD. (ClinicalTrials.gov number, NCT00599846.).
AbstractList To characterize longitudinal changes of reticular drusen (RDR) in subjects with geographic atrophy (GA) secondary to age-related macular degeneration in the multicenter, prospective natural history Geographic Atrophy Progression Study. Three-field confocal scanning laser ophthalmoscopy fundus autofluorescence (cSLO FAF, excitation [exc.] = 488 nm; emission [em.] 500-800 nm, Heidelberg Retina Angiograph/Spectralis) of 44 eyes of 22 patients with RDR (median age 77.6 years; range, 61-90 years) at baseline were identified in the study population and included for further analysis. Two independent readers determined the presence, topographic distribution, and pattern of RDR at baseline and at 18 months. Furthermore, the convex hull of the extent of RDR as the minimum polygon encompassing the entire area of RDR involvement was quantified. RDR lesion boundaries were clearly detectable in all directions within three-field FAF composite images in 16 eyes of 10 patients at both baseline and final visits. Over time, RDR-affected retinal area and RDR density increased. Quantitative analysis showed a mean average RDR extent of 53.7 mm(2) (95% confidence interval [95% CI]; 40.7; 66.8) at baseline. The mean differences for intraobserver agreements were 2.4 mm(2) (95% CI; -0.1; 4.9) for reader 1 and -0.6 mm(2) (95% CI; -2.3; 1.1) for reader 2. The mean difference of interobserver agreement was 0.9 mm(2) (95% CI; -0.8; 2.7). A mean growth rate of the RDR extent within the three-field FAF composite image of 4.4 mm(2)/y (95% CI; 1.9; 6.9) was measured. In vivo cSLO FAF imaging allows for both qualitative and quantitative mapping of longitudinal changes of RDR areas within a relatively short time period. Continuous enlargement of the affected retinal area indicates disease progression with regard to this phenotypic characteristic associated with GA in AMD. Systematic recordings of RDR progression appears warranted in future natural history and interventional studies in dry AMD. (ClinicalTrials.gov number, NCT00599846.).
To characterize longitudinal changes of reticular drusen (RDR) in subjects with geographic atrophy (GA) secondary to age-related macular degeneration in the multicenter, prospective natural history Geographic Atrophy Progression Study.PURPOSETo characterize longitudinal changes of reticular drusen (RDR) in subjects with geographic atrophy (GA) secondary to age-related macular degeneration in the multicenter, prospective natural history Geographic Atrophy Progression Study.Three-field confocal scanning laser ophthalmoscopy fundus autofluorescence (cSLO FAF, excitation [exc.] = 488 nm; emission [em.] 500-800 nm, Heidelberg Retina Angiograph/Spectralis) of 44 eyes of 22 patients with RDR (median age 77.6 years; range, 61-90 years) at baseline were identified in the study population and included for further analysis. Two independent readers determined the presence, topographic distribution, and pattern of RDR at baseline and at 18 months. Furthermore, the convex hull of the extent of RDR as the minimum polygon encompassing the entire area of RDR involvement was quantified.METHODSThree-field confocal scanning laser ophthalmoscopy fundus autofluorescence (cSLO FAF, excitation [exc.] = 488 nm; emission [em.] 500-800 nm, Heidelberg Retina Angiograph/Spectralis) of 44 eyes of 22 patients with RDR (median age 77.6 years; range, 61-90 years) at baseline were identified in the study population and included for further analysis. Two independent readers determined the presence, topographic distribution, and pattern of RDR at baseline and at 18 months. Furthermore, the convex hull of the extent of RDR as the minimum polygon encompassing the entire area of RDR involvement was quantified.RDR lesion boundaries were clearly detectable in all directions within three-field FAF composite images in 16 eyes of 10 patients at both baseline and final visits. Over time, RDR-affected retinal area and RDR density increased. Quantitative analysis showed a mean average RDR extent of 53.7 mm(2) (95% confidence interval [95% CI]; 40.7; 66.8) at baseline. The mean differences for intraobserver agreements were 2.4 mm(2) (95% CI; -0.1; 4.9) for reader 1 and -0.6 mm(2) (95% CI; -2.3; 1.1) for reader 2. The mean difference of interobserver agreement was 0.9 mm(2) (95% CI; -0.8; 2.7). A mean growth rate of the RDR extent within the three-field FAF composite image of 4.4 mm(2)/y (95% CI; 1.9; 6.9) was measured.RESULTSRDR lesion boundaries were clearly detectable in all directions within three-field FAF composite images in 16 eyes of 10 patients at both baseline and final visits. Over time, RDR-affected retinal area and RDR density increased. Quantitative analysis showed a mean average RDR extent of 53.7 mm(2) (95% confidence interval [95% CI]; 40.7; 66.8) at baseline. The mean differences for intraobserver agreements were 2.4 mm(2) (95% CI; -0.1; 4.9) for reader 1 and -0.6 mm(2) (95% CI; -2.3; 1.1) for reader 2. The mean difference of interobserver agreement was 0.9 mm(2) (95% CI; -0.8; 2.7). A mean growth rate of the RDR extent within the three-field FAF composite image of 4.4 mm(2)/y (95% CI; 1.9; 6.9) was measured.In vivo cSLO FAF imaging allows for both qualitative and quantitative mapping of longitudinal changes of RDR areas within a relatively short time period. Continuous enlargement of the affected retinal area indicates disease progression with regard to this phenotypic characteristic associated with GA in AMD. Systematic recordings of RDR progression appears warranted in future natural history and interventional studies in dry AMD. (ClinicalTrials.gov number, NCT00599846.).CONCLUSIONSIn vivo cSLO FAF imaging allows for both qualitative and quantitative mapping of longitudinal changes of RDR areas within a relatively short time period. Continuous enlargement of the affected retinal area indicates disease progression with regard to this phenotypic characteristic associated with GA in AMD. Systematic recordings of RDR progression appears warranted in future natural history and interventional studies in dry AMD. (ClinicalTrials.gov number, NCT00599846.).
Author Fleckenstein, Monika
Steinberg, Julia S.
Holz, Frank G.
Jaffe, Glenn J.
Auge, Jasmin
Schmitz-Valckenberg, Steffen
Author_xml – sequence: 1
  givenname: Julia S.
  surname: Steinberg
  fullname: Steinberg, Julia S.
  organization: Department of Ophthalmology, University of Bonn, Bonn, Germany
– sequence: 2
  givenname: Jasmin
  surname: Auge
  fullname: Auge, Jasmin
  organization: Department of Ophthalmology, University of Bonn, Bonn, Germany
– sequence: 3
  givenname: Glenn J.
  surname: Jaffe
  fullname: Jaffe, Glenn J.
  organization: Department of Ophthalmology, Duke University Eye Center, Durham, North Carolina
– sequence: 4
  givenname: Monika
  surname: Fleckenstein
  fullname: Fleckenstein, Monika
  organization: Department of Ophthalmology, University of Bonn, Bonn, Germany
– sequence: 5
  givenname: Frank G.
  surname: Holz
  fullname: Holz, Frank G.
  organization: Department of Ophthalmology, University of Bonn, Bonn, Germany
– sequence: 6
  givenname: Steffen
  surname: Schmitz-Valckenberg
  fullname: Schmitz-Valckenberg, Steffen
  organization: Department of Ophthalmology, University of Bonn, Bonn, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23633663$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtLxDAUhYMozkOXbiVLNx3zsGm7HEYdhRFhGHBZ0vS2E-kkNUmF-fd2HooIbu69i-8eOOeM0KmxBhC6omRCqUhutf30E8oiSmOenqAhjWMWxUnKT3_dAzTy_p0QRikj52jAuOBcCD5E7cKaWoeu1EY2eNqPrdce2wovIWjVNdLhe9d5MHjqvVVaBijxmw5rPAdbO9mutcLT4Gy73mLdUzVES2j22Is8CkANBpwM2poLdFbJxsPlcY_R6vFhNXuKFq_z59l0ESmW8RABU0UhVVIKKlgiq1LwhJcVp0kKkN1JITNOEpUClxkhVZZAWmVZyiomyrQgfIxuDrKtsx8d-JBvtFfQNNKA7XxOe_spI3Gf2hhdH9Gu2ECZt05vpNvm3yH1QHQAlLPeO6h-EEryXQn5roScsnxfQs_zP7zSYW8-OKmbf76-AJjsjMk
CitedBy_id crossref_primary_10_1016_j_pdpdt_2020_102171
crossref_primary_10_1074_jbc_M116_744656
crossref_primary_10_1167_iovs_61_13_19
crossref_primary_10_1111_cxo_12842
crossref_primary_10_1136_bjophthalmol_2014_305339
crossref_primary_10_1159_000368168
crossref_primary_10_1016_j_ophtha_2015_09_036
crossref_primary_10_1016_j_ophtha_2017_08_038
crossref_primary_10_1007_s00417_014_2858_1
crossref_primary_10_1016_j_ophtha_2018_11_030
crossref_primary_10_1007_s00417_021_05147_7
crossref_primary_10_1016_j_ajo_2014_01_025
crossref_primary_10_1097_IAE_0000000000000666
crossref_primary_10_1155_2020_9457457
crossref_primary_10_1007_s00347_013_2965_0
crossref_primary_10_1371_journal_pone_0149030
crossref_primary_10_3390_jcm3041335
crossref_primary_10_1016_j_ophtha_2013_10_043
crossref_primary_10_1016_j_ophtha_2015_12_034
crossref_primary_10_1007_s00417_023_06022_3
crossref_primary_10_3390_biomedicines10102370
crossref_primary_10_3928_23258160_20150521_06
crossref_primary_10_1016_j_xops_2024_100620
crossref_primary_10_1111_cxo_12894
crossref_primary_10_1016_j_survophthal_2016_02_005
crossref_primary_10_1016_j_apjo_2024_100036
crossref_primary_10_1167_iovs_62_1_33
crossref_primary_10_1097_IAE_0000000000002657
crossref_primary_10_3109_13816810_2013_841962
crossref_primary_10_1016_j_ophtha_2022_11_026
crossref_primary_10_1097_IAE_0000000000001504
crossref_primary_10_1097_OPX_0000000000000287
crossref_primary_10_1016_j_ophtha_2018_09_039
crossref_primary_10_1136_bjophthalmol_2014_306535
crossref_primary_10_1016_j_ajo_2016_04_025
ContentType Journal Article
Contributor Mohand-Said, S
Holz, F G
Heier, J S
Arnold, J
Wiedemann, P
Guymer, R
Midena, E
Halperin, L S
He, Y G
Chakravarthy, U
Wells, 3rd, J A
Loewenstein, A
Bandello, F
Downes, S
Sahel, J A
Strachwitz, Cv
Georgopoulus, M
Wolf, S
Brown, D M
Cowan, G
Anand, R
Boyer, D S
Russell, S R
Pollack, A
Leys, A
Staurenghi, G
Pauleikhoff, D
Pruente, C
Wolf-Schnurrbusch, U
Tufail, A
Silva, R
Agostini, H J
Teske, M P
Singerman
Callanan, D
Patel
Contributor_xml – sequence: 1
  givenname: H J
  surname: Agostini
  fullname: Agostini, H J
– sequence: 2
  givenname: R
  surname: Anand
  fullname: Anand, R
– sequence: 3
  givenname: J
  surname: Arnold
  fullname: Arnold, J
– sequence: 4
  givenname: F
  surname: Bandello
  fullname: Bandello, F
– sequence: 5
  givenname: D S
  surname: Boyer
  fullname: Boyer, D S
– sequence: 6
  givenname: D M
  surname: Brown
  fullname: Brown, D M
– sequence: 7
  givenname: D
  surname: Callanan
  fullname: Callanan, D
– sequence: 8
  givenname: U
  surname: Chakravarthy
  fullname: Chakravarthy, U
– sequence: 9
  givenname: G
  surname: Cowan
  fullname: Cowan, G
– sequence: 10
  givenname: S
  surname: Downes
  fullname: Downes, S
– sequence: 11
  givenname: R
  surname: Guymer
  fullname: Guymer, R
– sequence: 12
  givenname: L S
  surname: Halperin
  fullname: Halperin, L S
– sequence: 13
  givenname: Y G
  surname: He
  fullname: He, Y G
– sequence: 14
  givenname: J S
  surname: Heier
  fullname: Heier, J S
– sequence: 15
  givenname: F G
  surname: Holz
  fullname: Holz, F G
– sequence: 16
  givenname: A
  surname: Leys
  fullname: Leys, A
– sequence: 17
  givenname: A
  surname: Loewenstein
  fullname: Loewenstein, A
– sequence: 18
  givenname: E
  surname: Midena
  fullname: Midena, E
– sequence: 19
  surname: Patel
  fullname: Patel
– sequence: 20
  givenname: D
  surname: Pauleikhoff
  fullname: Pauleikhoff, D
– sequence: 21
  givenname: A
  surname: Pollack
  fullname: Pollack, A
– sequence: 22
  givenname: C
  surname: Pruente
  fullname: Pruente, C
– sequence: 23
  givenname: M
  surname: Georgopoulus
  fullname: Georgopoulus, M
– sequence: 24
  givenname: S R
  surname: Russell
  fullname: Russell, S R
– sequence: 25
  givenname: R
  surname: Silva
  fullname: Silva, R
– sequence: 26
  surname: Singerman
  fullname: Singerman
– sequence: 27
  givenname: J A
  surname: Sahel
  fullname: Sahel, J A
– sequence: 28
  givenname: S
  surname: Mohand-Said
  fullname: Mohand-Said, S
– sequence: 29
  givenname: G
  surname: Staurenghi
  fullname: Staurenghi, G
– sequence: 30
  givenname: M P
  surname: Teske
  fullname: Teske, M P
– sequence: 31
  givenname: A
  surname: Tufail
  fullname: Tufail, A
– sequence: 32
  givenname: Cv
  surname: Strachwitz
  fullname: Strachwitz, Cv
– sequence: 33
  givenname: J A
  surname: Wells, 3rd
  fullname: Wells, 3rd, J A
– sequence: 34
  givenname: P
  surname: Wiedemann
  fullname: Wiedemann, P
– sequence: 35
  givenname: S
  surname: Wolf
  fullname: Wolf, S
– sequence: 36
  givenname: U
  surname: Wolf-Schnurrbusch
  fullname: Wolf-Schnurrbusch, U
CorporateAuthor GAP Study Group
CorporateAuthor_xml – name: GAP Study Group
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1167/iovs.12-11538
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1552-5783
ExternalDocumentID 23633663
10_1167_iovs_12_11538
Genre Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
18M
2WC
34G
39C
5GY
5RE
AAYXX
ACGFO
ACNCT
ADBBV
AENEX
AFOSN
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GROUPED_DOAJ
GX1
N9A
OK1
P2P
RPM
SJN
TR2
TRV
W8F
WH7
WOQ
WOW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c293t-e2cbbac7d61627afd6373df3178ee94a6a9307c8e3a900f97e8f9982f26d8b03
ISSN 1552-5783
IngestDate Thu Sep 04 22:41:11 EDT 2025
Thu Apr 03 07:09:40 EDT 2025
Tue Jul 01 02:29:59 EDT 2025
Thu Apr 24 23:10:33 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords age-related macular degeneration
scanning laser ophthalmoscopy
fundus autofluorescence
reticular drusen
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c293t-e2cbbac7d61627afd6373df3178ee94a6a9307c8e3a900f97e8f9982f26d8b03
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 23633663
PQID 1366820515
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1366820515
pubmed_primary_23633663
crossref_primary_10_1167_iovs_12_11538
crossref_citationtrail_10_1167_iovs_12_11538
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-Jun-10
PublicationDateYYYYMMDD 2013-06-10
PublicationDate_xml – month: 06
  year: 2013
  text: 2013-Jun-10
  day: 10
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Investigative ophthalmology & visual science
PublicationTitleAlternate Invest Ophthalmol Vis Sci
PublicationYear 2013
SSID ssj0021120
Score 2.2848864
Snippet To characterize longitudinal changes of reticular drusen (RDR) in subjects with geographic atrophy (GA) secondary to age-related macular degeneration in the...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 4054
SubjectTerms Aged
Aged, 80 and over
Databases, Factual
Disease Progression
Female
Fluorescein Angiography
Follow-Up Studies
Geographic Atrophy - pathology
Humans
Longitudinal Studies
Macular Degeneration - pathology
Male
Middle Aged
Optic Disk Drusen - pathology
Prospective Studies
Title Longitudinal Analysis of Reticular Drusen Associated With Geographic Atrophy in Age-Related Macular Degeneration
URI https://www.ncbi.nlm.nih.gov/pubmed/23633663
https://www.proquest.com/docview/1366820515
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAviDvlJiMhXoZLbnWSxwltjNKNBzKpb5Ed21thTaY26QN_gT_N8SWXSZ00eIki17Eqn0_H3_G5IfReRamYRoEkXiA4iYpIksRXKUklY4lHZeEJnY18ckqPz6LZYroYjf4Mopaamk-K3zvzSv5HqjAGctVZsv8g2W5RGIB3kC88QcLwvJWM55XuNtQI09mKDcqLmNREE2Aq1vqOZZ85KbTB5ue29_mFrtZaryvYa33xAbqFmOQWmLZibgF5bipTdwL82ca-dwU6tnIfVqgv2OXKVnTScNouN02bcNmj54durtmGlOncbNbfvR40ts37jG1Wyw6zM6aUGf4C52PZe7EAcKCAgNy6bp1aOf1iw0sM01CCuHBWp3enYBPHtqfNRO4Yc8raVpx2oBxqXiCe0e4jgWqn9LLabiZ-QHyt4fuzr_X3n37Pj87m8zw7XGR30N0gjq3P_-u3znr3bY3P7l-1BVtp_Ona4tcJzg1Wi2Ev2UP0wJkd-MBi6BEayfIxunfiAiueoKshlHALJVwp3EEJWyjhHkpYQwn3UMIOSngJs3ooYQclPITSU5QdHWafj4lrxkEKYIQ1kUHBOStiQX0axEwJGsahUEA_EynTiFGWwnFRJDJkqeepNJaJAlM-UAEVCffCZ2ivrEr5AmHGwYiWHKh_zCJPSRbRKfdFCETUT1PGx-hju4F54QrV634pl7kxWGmc6_3O_SA3-z1GH7rpV7ZCy00T37XSyEGHascYK2XVwIyQUmDCQO3H6LkVU7dUENIQfg5f3uLrV-h-D-7XaK9eN_INcNaavzVY-gsBs6A8
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Longitudinal+analysis+of+reticular+drusen+associated+with+geographic+atrophy+in+age-related+macular+degeneration&rft.jtitle=Investigative+ophthalmology+%26+visual+science&rft.au=Steinberg%2C+Julia+S&rft.au=Auge%2C+Jasmin&rft.au=Jaffe%2C+Glenn+J&rft.au=Fleckenstein%2C+Monika&rft.date=2013-06-10&rft.issn=1552-5783&rft.eissn=1552-5783&rft.volume=54&rft.issue=6&rft.spage=4054&rft_id=info:doi/10.1167%2Fiovs.12-11538&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5783&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5783&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5783&client=summon